ZA201000959B - The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases - Google Patents

The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases

Info

Publication number
ZA201000959B
ZA201000959B ZA201000959A ZA201000959A ZA201000959B ZA 201000959 B ZA201000959 B ZA 201000959B ZA 201000959 A ZA201000959 A ZA 201000959A ZA 201000959 A ZA201000959 A ZA 201000959A ZA 201000959 B ZA201000959 B ZA 201000959B
Authority
ZA
South Africa
Prior art keywords
extracts
drug
treatment
effective component
cancer diseases
Prior art date
Application number
ZA201000959A
Other languages
English (en)
Inventor
Matthias-Heinrich Kreuter
Jian Ying Yam
Karin Berger-Bueter
Original Assignee
Viridis Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viridis Pharmaceutical Ltd filed Critical Viridis Pharmaceutical Ltd
Publication of ZA201000959B publication Critical patent/ZA201000959B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA201000959A 2007-08-16 2010-02-10 The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases ZA201000959B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01289/07A CH698627B1 (de) 2007-08-16 2007-08-16 Herstellung und Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen.

Publications (1)

Publication Number Publication Date
ZA201000959B true ZA201000959B (en) 2010-10-27

Family

ID=38668948

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201000959A ZA201000959B (en) 2007-08-16 2010-02-10 The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases

Country Status (14)

Country Link
US (3) US8404286B2 (enExample)
EP (1) EP2182966B1 (enExample)
JP (1) JP5378379B2 (enExample)
KR (1) KR20100089815A (enExample)
CN (1) CN102065875B (enExample)
AU (1) AU2008286636B2 (enExample)
BR (1) BRPI0815188A2 (enExample)
CA (1) CA2696499A1 (enExample)
CH (1) CH698627B1 (enExample)
ES (1) ES2392310T3 (enExample)
PL (1) PL2182966T3 (enExample)
RU (1) RU2470657C2 (enExample)
WO (1) WO2009021347A1 (enExample)
ZA (1) ZA201000959B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI472333B (zh) * 2008-06-26 2015-02-11 Piramal Entpr Ltd 治療口腔念珠菌病之口服草本組成物
JP5806231B2 (ja) * 2009-12-21 2015-11-10 アセフ エス．アー． 勃起障害の治療における血管拡張剤としてのクベビン、ジベンジルブチルロラクトリンリグナン、その半合成誘導体および合成誘導体、ならびに他のリグナンおよびネオリグナン
WO2014027857A1 (ko) * 2012-08-16 2014-02-20 부산대학교 산학협력단 알파-이소-쿠베벤 또는 알파-이소-쿠베베놀을 유효성분으로 포함하는 감염성 및 염증성 질환의 예방 또는 치료용 조성물
WO2014086379A1 (en) 2012-12-03 2014-06-12 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Lignan compositions
FR3085846B1 (fr) * 2018-09-13 2022-01-21 Robertet Sa Utilisation d’extrait de p.nigrum, p. cubeba et/ou s. therebentifolius dans des preparations cosmetiques pour favoriser la pousse des poils
JP7197908B2 (ja) * 2019-03-04 2022-12-28 株式会社ナチュファルマ琉球 骨減少性疾患の予防及び／又は治療用組成物
CN114574286B (zh) * 2022-02-18 2024-03-22 中国热带农业科学院香料饮料研究所 一种具有抗炎活性的胡椒精油及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815177D0 (en) * 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
JP3091962B2 (ja) * 1998-09-25 2000-09-25 アルプス薬品工業株式会社 テストステロン−５α−レダクターゼ阻害剤
WO2003047551A1 (en) * 2001-11-29 2003-06-12 Penwest Pharmaceutical Company Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
BR0201237A (pt) 2002-03-25 2003-12-02 Fundacao De Amparo A Pesquisa Processo de obtenção de lignanas dibenzilbutirolactÈnicas, processo de obtenção de derivados sintéticos de lignanas ostentando atividades quimioprofilática e terapêutica antichagásica
US20030228383A1 (en) * 2002-06-06 2003-12-11 J.B. Chemicals & Pharmaceuticals, Ltd. Herbal cough formulations and process for the preparation thereof
JP2004160165A (ja) * 2002-09-17 2004-06-10 Pauretsuku:Kk 生薬成分製剤の造粒方法
EP1581237B1 (en) * 2002-12-30 2007-06-27 Council of Scientific and Industrial Research Development of an anti-cough, anti-tussive and throat soothing herbal formulation
JP4319417B2 (ja) * 2003-01-30 2009-08-26 学校法人近畿大学 メラニン産生不全症治療剤
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer

Also Published As

Publication number Publication date
KR20100089815A (ko) 2010-08-12
EP2182966B1 (de) 2012-08-08
AU2008286636A1 (en) 2009-02-19
RU2470657C2 (ru) 2012-12-27
WO2009021347A1 (de) 2009-02-19
AU2008286636B2 (en) 2013-10-24
US20110135760A1 (en) 2011-06-09
JP5378379B2 (ja) 2013-12-25
CH698627B1 (de) 2009-09-15
CN102065875B (zh) 2013-07-17
RU2010109750A (ru) 2011-09-27
US9248156B2 (en) 2016-02-02
BRPI0815188A2 (pt) 2015-03-31
US20160193272A1 (en) 2016-07-07
CN102065875A (zh) 2011-05-18
PL2182966T3 (pl) 2013-01-31
CA2696499A1 (en) 2009-02-19
US20130251826A1 (en) 2013-09-26
ES2392310T3 (es) 2012-12-07
US8404286B2 (en) 2013-03-26
JP2010536718A (ja) 2010-12-02
EP2182966A1 (de) 2010-05-12

Similar Documents

Publication Publication Date Title
IL196470A (en) Antagonist antibody for cancer treatment
IL206563A0 (en) Medicament for the treatment of cancer of the pancreas
PL1927363T3 (pl) Ekstrakt do profilaktyki lub leczenia chorób zakrzepowych
PT2101731T (pt) Endoxifeno para utilização no tratamento de cancro
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
EP2121105A4 (en) FAST EXCHANGE CATHETER IMPROVED
ZA201000959B (en) The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
IL201562A0 (en) Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
SI2234631T1 (sl) Spojine in postopki za zdravljenje ĺ˝ilne bolezni
ZA201007362B (en) Conjugates for the treatment of mesothelioma
IL200966A0 (en) Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer
ZA200806949B (en) Medicinal formulation for the treatment for hepatitis C
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
IL226362A0 (en) compounds, and methods for treating cancer
GB2443588B (en) A pharmaceutical composition useful for the treatment of prostate cancer
EP1753400A4 (en) PHARMACEUTICAL FOR ZIPRASIDONE
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP2344528A4 (en) DRUGS AND FIBROSIS, ITS COMPOSITION AND USES
GB0606322D0 (en) The medical eradicator
GB0618309D0 (en) Compositions and methods for the treatment of disease
GB0602857D0 (en) The treatment of sialorrhoea
GB0616532D0 (en) Molecular methods for the treatment of disease